Quantum Healthcare (V8Y.SI) rises to S$0.002 on 23 Jan 2026: assess liquidity
V8Y.SI stock jumped intraday to S$0.002 on 23 Jan 2026, a 100.00% rise from the previous close and a clear intraday mover on the Singapore Exchange (SES). This short note tracks the price move, trading quantity and the key ratios that matter for small-cap healthcare device names. We flag liquidity and valuation risk, show Meyka AI forecast targets, and outline practical entry and stop levels for traders watching Quantum Healthcare Limited (V8Y.SI) in Singapore (SGD).
Intraday snapshot: V8Y.SI stock price and volume
Quantum Healthcare Limited (V8Y.SI) traded between S$0.001 and S$0.002 today, closing at S$0.002 after a S$0.001 intraday gain. Market capitalisation is approximately S$8,014,501.00 with 8,014,501,000 shares outstanding. Reported volume was 2,300 against an average volume of 572,415.00, highlighting low absolute liquidity despite the price move.
Catalyst check: V8Y.SI stock drivers and news
There is no public earnings or regulatory announcement tied to the move; the company’s website shows ongoing vascular device and dental services operations. The intraday jump appears driven by thin-order-book dynamics and short-term trader interest rather than fresh corporate news. See company filings and background on the official site for corporate updates source.
Fundamentals and valuation: V8Y.SI stock financials and ratios
Quantum Healthcare’s trailing metrics show stress in fundamentals: current ratio 0.25, PE ratio -4.37 and price-to-sales 0.62. Operating cash flow per share is 0.00017 and free cash flow per share is 0.00014, indicating small positive cash generation on tiny per-share values. The company’s enterprise value is S$14,672,501.00, implying an EV/Sales of 1.13 and tight working capital position. These ratios point to thin buffers for shocks.
Technicals and liquidity: V8Y.SI stock trading metrics
Momentum indicators are muted: RSI 47.22 and ADX 18.68 show no strong trend. On-balance volume reads -6,414,300.00, reflecting prior outflows. The price averages are 50-day 0.00116 and 200-day 0.00129, with the intraday high at 0.002. Low trading depth makes intraday spikes likely and increases execution risk for larger orders.
Meyka AI rates V8Y.SI with a score out of 100 and forecast
Meyka AI rates V8Y.SI with a score out of 100: 64.92, Grade B, Suggestion: HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst consensus. Company analyst consensus on 22 Jan 2026 shows a C rating and a Sell recommendation in the external summary.
Meyka AI’s forecast model projects S$0.01122 in 1 year, S$0.03107 in 3 years and S$0.05092 in 5 years. Compared with today’s S$0.002, the 1-year projection implies an upside of 460.91%, the 3-year projection implies 1,453.74% and the 5-year projection implies 2,446.22%. Forecasts are model-based projections and not guarantees.
Trading strategy: V8Y.SI stock entry, targets and risks
For short-term traders, a conservative intraday target is S$0.003 with a tight stop below S$0.001 to limit downside from low liquidity. For medium-term investors, a 1-year price target aligned with Meyka AI is S$0.011 and a cautious 3-year target is S$0.031. Risk factors include negative net income per share, low current ratio, possible delisting risk on sustained inactivity, and high volatility. For live quotes and order placement see the Meyka stock page for V8Y.SI source.
Final Thoughts
V8Y.SI stock is trading as a thinly liquid intraday mover after a 100.00% price uptick to S$0.002 on 23 Jan 2026. Fundamentals show constrained liquidity with a current ratio 0.25, negative trailing earnings, and small market capitalisation S$8,014,501.00. Meyka AI’s forecast model projects S$0.01122 in one year, an implied upside of 460.91% versus today’s price; this projection is model-driven and not guaranteed. Our proprietary grade is 64.92 (B, HOLD) and reflects mixed signals from sector peers and thin balance sheet metrics. Traders should prioritise execution risk controls, small position sizing and clear stop-loss levels when trading V8Y.SI stock on SES in SGD. Meyka AI provides this as an AI-powered market analysis platform insight, not investment advice.
FAQs
What caused the intraday move in V8Y.SI stock on 23 Jan 2026?
The move looks driven by thin liquidity and short-term trader activity rather than a specific corporate announcement. There were no public earnings or regulatory filings tied to the spike.
What is Meyka AI’s 1-year forecast for V8Y.SI stock?
Meyka AI’s forecast model projects S$0.01122 in one year, implying an upside of 460.91% versus the current price of S$0.002. Forecasts are model-based projections and not guarantees.
How risky is trading V8Y.SI stock right now?
High risk: low market cap, low current ratio 0.25, negative trailing EPS, and thin order books make price swings and slippage likely. Use small sizes and strict stops.
Where can I find official company information for V8Y.SI stock?
Official company information and filings are on Quantum Healthcare’s website and regulator disclosures. Start with the corporate site for contact details and business updates source.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
